tradingkey.logo

ReShape Lifesciences Inc

RSLS
Ver gráfico detallado

3.920USD

0.000
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
10.29MCap. mercado
PérdidaP/E TTM

ReShape Lifesciences Inc

3.920

0.000
Intraday
1m
30m
1h
D
W
M
D

Hoy

0.00%

5 Días

0.00%

1 Mes

0.00%

6 Meses

-75.11%

Año hasta la fecha

-96.48%

Un año

-97.83%

Ver gráfico detallado

Puntuación de acciones TradingKey

Sin datos de puntuación

Noticias

Próximamente más noticias, permanezca atento...

Indicadores financieros

BPA

Sin datos

Ingresos totales

Sin datos

Compañía

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Símbolo de cotizaciónRSLS
CompañíaReShape Lifesciences Inc
Director ejecutivoMr. Paul F. Hickey
Sitio Webhttps://www.reshapelifesciences.com/obalon/
KeyAI